Found: 14
Select item for more details and to access through your institution.
Comparable Outcomes for Hematologic Malignancies after HLA-Haploidentical Transplantation with Posttransplantation Cyclophosphamide and HLA-Matched Transplantation.
- Published in:
- Advances in Hematology, 2015, p. 1, doi. 10.1155/2015/431923
- By:
- Publication type:
- Article
Risk Factors for Graft-Versus-Host Disease after HLA-Haploidentical Transplantation with Posttransplantation Cyclophosphamide.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S125, doi. 10.1016/j.clml.2016.07.183
- By:
- Publication type:
- Article
Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purging for acute myeloid leukaemia beyond first remission: a 10-year experience.
- Published in:
- British Journal of Haematology, 2002, v. 117, n. 4, p. 907, doi. 10.1046/j.1365-2141.2002.03530.x
- By:
- Publication type:
- Article
Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide.
- Published in:
- Pediatric Reports, 2011, v. 3, p. 43, doi. 10.4081/pr.2011.s2.e15
- By:
- Publication type:
- Article
Hyperinflammatory syndrome resembling haemophagocytic lymphohistiocytosis following axicabtagene ciloleucel and brexucabtagene autoleucel.
- Published in:
- British Journal of Haematology, 2022, v. 199, n. 5, p. 720, doi. 10.1111/bjh.18454
- By:
- Publication type:
- Article
Incidence and impact of community respiratory viral infections in post‐transplant cyclophosphamide‐based graft‐versus‐host disease prophylaxis and haploidentical stem cell transplantation.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 1, p. 145, doi. 10.1111/bjh.17563
- By:
- Publication type:
- Article
Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-κB.
- Published in:
- Nature Cell Biology, 2001, v. 3, n. 4, p. 409, doi. 10.1038/35070096
- By:
- Publication type:
- Article
Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myeloma.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 288, p. 1, doi. 10.1126/scitranslmed.aaa7014
- By:
- Publication type:
- Article
Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide.
- Published in:
- Science Translational Medicine, 2013, v. 5, n. 211, p. 1, doi. 10.1126/scitranslmed.3006960
- By:
- Publication type:
- Article
Bone marrow transplantation for sickle cell anemia: Progress and prospects.
- Published in:
- Pediatric Blood & Cancer, 2005, v. 44, n. 5, p. 436, doi. 10.1002/pbc.20169
- By:
- Publication type:
- Article
High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation.
- Published in:
- Immunologic Research, 2010, v. 47, n. 1-3, p. 65, doi. 10.1007/s12026-009-8139-0
- By:
- Publication type:
- Article
Immunotherapy of established tumors using bone marrow transplantation with antigen gene-modified hematopoietic stem cells.
- Published in:
- Nature Medicine, 2003, v. 9, n. 7, p. 952, doi. 10.1038/nm882
- By:
- Publication type:
- Article
Transplantation tolerance: from theory to clinic.
- Published in:
- Immunological Reviews, 2014, v. 258, n. 1, p. 64, doi. 10.1111/imr.12154
- By:
- Publication type:
- Article
How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?
- Published in:
- Journal of Hematology & Oncology, 2016, v. 9, p. 1, doi. 10.1186/s13045-016-0265-2
- By:
- Publication type:
- Article